Guava automated.jpg
FA info icon.svg Angle down icon.svg Medical equipment data
Health topic HIV/AIDS
Health classification Diagnosis
FA info icon.svg Angle down icon.svg Project data
Location Massachusetts, United States
Status Commercialized
Replicated No
OKH Manifest Download

Problem being addressed[edit | edit source]

CD4 T cell counts are necessary for the monitoring and diagnosis of HIV/AIDS. These tests are often difficult and expensive. A low-cost, easy to use option is needed for use in resource-limited settings.

Detailed description of the solution[edit | edit source]

The Guava Auto CD4/CD4% System is a unique bench-top instrument equiped with acquisition software that health providers can use to easily monitor patients' T-lymphocytes. The Guava Auto CD4/CD4% System provides reliable results with minimum technical expertise to operate. The system provides absolute CD4 counts, CD4% of total lymphocytes, and total lymphocyte count.

Designed by[edit | edit source]

  • Designed by: Guava Technologies, Inc., but Millipore acquired Guava in 2009.
  • Manufacturing: Headquarters located in Billerica, Massachusetts, USA.

When and where it was tested/implemented[edit | edit source]

Testing of the device has been done in the United States. Performance has been evaluated in multiple laboratories against several well-accepted methods for determining absolute CD4 counts and CD4% values. Studies were performed on both adult and pediatric HIV samples as well as normal samples. Auto CD4/CD4% Assay test results were compared to results from other well established methods for CD4 analysis, showing consistently comparable results.

References[edit | edit source]

Peer-reviewed publication[edit | edit source]

The 2009 WHO "Review of CD4 Technologies" stated that there have been no peer-reviewed independent performance evaluation data for the Guava Auto CD4. PDF cited here.

Other internally generated reports[edit | edit source]

Externally generated reports[edit | edit source]

Mergia, A., Elad, K., Sharp, M., Fishwild, D., O'Connell, B., Bredt, B., & Tyagarajan, K. (February, 2005). Performance of Aged, TransFix-Treated Blood in the Guava EasyCD4 and EasyCD8 Assays. Guava Technologies. Presented at the 12th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts USA.

FA info icon.svg Angle down icon.svg Page data
Part of Global Health Medical Device Compendium
SDG SDG03 Good health and well-being
Authors Eva Shiu
License CC-BY-SA-3.0
Organizations Merck Millipore
Language English (en)
Related 0 subpages, 3 pages link here
Aliases Guava Auto CD4/CD4% System
Impact 503 page views
Created January 25, 2012 by Eva Shiu
Modified January 29, 2024 by Felipe Schenone
Cookies help us deliver our services. By using our services, you agree to our use of cookies.